Related Experiment Video
Updated: Aug 7, 2026
04:18
A Seamless Cloning Approach for Porcine Reproductive and Respiratory Syndrome Virus Expression Vector Construction
Published on: May 17, 2024
[Construction and identification of plasmid vector encoding two survivin shRNA]
Guang-tian Yang1, Yu-xi Shan, Dong-rong Yang
1Department of Urology, the Second Affiliated Hospital, Soochow University, Suzhou, Jiangsu 215004, China.
Zhonghua Nan Ke Xue = National Journal of Andrology
|July 13, 2006
Summary
Researchers successfully created gene expression plasmids with survivin short hairpin RNA (shRNA) for targeted gene therapy in prostate cancer (PCa). This provides a foundation for future PCa treatment research.
Area of Science:
- Molecular Biology
- Oncology
- Gene Therapy
Background:
- Prostatic carcinoma (PCa) is a significant health concern.
- Survivin is a protein implicated in cancer cell survival and proliferation.
- Targeted gene therapy offers a promising approach for cancer treatment.
Purpose of the Study:
- To construct and identify eukaryotic expression plasmids encoding survivin short hairpin RNA (shRNA).
- To develop tools for targeted gene therapy research in prostatic carcinoma.
Main Methods:
- Design and synthesis of two distinct survivin shRNAs.
- Cloning of shRNAs into eukaryotic expression plasmids.
- Confirmation of recombinant plasmids via sequencing and restriction digestion followed by agarose gel electrophoresis.
Main Results:
- Successfully constructed recombinant plasmids containing survivin shRNA sequences.
- Verified the presence and integrity of the cloned sequences.
Conclusions:
- The successful construction of these recombinant plasmids provides a robust foundation for further research into targeted gene therapy for prostatic carcinoma.
- This work facilitates the development of novel therapeutic strategies against PCa.
